kio-301
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 10, 2022 (NCT05282953)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Loading structure…
SMILES
CCN(Cc1ccccc1)c1ccc(/N=N/c2ccc(NC(=O)C[N+](CC)(CC)CC)cc2)cc1- Mol. weight
- 472.66 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4796560 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06628947 | Phase 2 | Mar 31, 2025 | Kiora Pharmaceuticals, Inc., University of Adelaide |
| NCT05282953 | Phase 1 | Nov 10, 2022 | Kiora Pharmaceuticals, Inc., University of Adelaide |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Kiora Pharmaceuticals, Inc. | For profit | 2 | 2 | 2 | 2022 |
| University of Adelaide | Academic/Hospital | 2 | 0 | 2 | 2022 |
2 organizations
Page 1 / 1